What sector does Mochida Pharmaceutical Co.,Ltd. belong to?

Mochida Pharmaceutical Co.,Ltd. operates in the Pharmaceuticals sector, specifically the Pharmaceutical industry, and is listed on the US markets.

What is the current share price of 4534?

As of the latest available quote, 4534 traded at ¥3,160.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 4534?

Mochida Pharmaceutical Co.,Ltd. has a price-to-earnings (P/E) ratio of about 14.16. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 4534?

The market capitalisation of Mochida Pharmaceutical Co.,Ltd. is approximately ¥112.01B.

Is Mochida Pharmaceutical Co.,Ltd. profitable?

For its latest reported financial year, Mochida Pharmaceutical Co.,Ltd. recorded a net profit margin of about 6.76%.

Does 4534 pay a dividend?

Mochida Pharmaceutical Co.,Ltd. currently has a dividend yield of about 2.52%.

What is the return on equity (ROE) of 4534?

Mochida Pharmaceutical Co.,Ltd. has a return on equity (ROE) of about 5.80%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 4534?

Over the past 52 weeks, 4534 has traded between a low of ¥2,929.00 and a high of ¥3,965.00.

Mochida Pharmaceutical Co.,Ltd.

4534 TSE Pharmaceuticals Pharmaceutical

TSE Prime

¥3,160.00

-0.47%

Delayed · cached 15 min

Fair value analysis

4534

Mochida Pharmaceutical Co.,Ltd.

¥3,160.00

Close used for this calculation

¥3,657.02Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

57/100

Profitability10/25

Returns11/25

Balance Sheet18/25

Efficiency18/25

Growth11/25

Good

Quality radar

Consensus fair value

¥3,657.02

Below FV

▲ +15.7% against the close used

Model range ¥1,019.34 – ¥4,459.20

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear¥1,019.34Fair value¥3,657.02Bull¥4,459.20

FairClose

52-week traded range

52W low ¥2,948.0052W high ¥3,965.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Mochida Pharmaceutical Co.,Ltd. closed at ¥3,160.00, 13.6% below the consensus fair value of ¥3,657.02 drawn from 9 valuation models.

Financial DNA score 57/100 — Good. P/E of 14.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

¥4,178.84

+32.2%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

¥4,451.47

+40.9%

√(22.5 × EPS × BVPS)

EPS=222.96, BVPS=3950

P/E Fair Value

¥4,459.20

+41.1%

EPS × 20x (sector P/E)

EPS=222.96, Sector P/E=20x

Peter Lynch (PEG)

¥1,562.95

-50.5%

EPS × Growth% (PEG = 1 is fair)

EPS=222.96, g=7%

EV/EBITDA

¥3,421.00

+8.3%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=13.13B

Dividend Discount (DDM)

¥1,019.34

-67.7%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=79.95, r=10%, g=2%

Book Value (P/B)

¥1,580.00

-50.0%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=3950, ROE=5.8%, g=3%, r=10%

Reverse DCF

¥3,160.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 2.5% | Historical: -7%

Margin of Safety

¥3,272.38

+3.6%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=4363.17, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer